Spiegel yohimbine
Producer: Solvay Pharmaceuticals, (Solvey Pharmasyyutikalz) GmbH Germany
Code of automatic telephone exchange: G04BE04
Release form: Firm dosage forms. Tablets.
General characteristics. Structure:
Active agent: yohimbine hydrochloride of 5 mg
Excipients: starch corn — 6 mg; arabic gum — 6 mg; lactoses monohydrate — 110 mg; sucrose — 116 mg; stearic acid — 3 mg; talc — 4 mg.
Pharmacological properties:
Pharmacological action - the raising libido and a potentiality.
Selectively blocks central and peripheral presynaptic and postsynaptic (in high doses) alfa2-adrenoceptors. Has a promoting effect on TsNS.
Pharmacodynamics. Raises a sexual inclination, strengthens an erection, normalizes a potentiality.
Indications to use:
Strengthening of a potentiality (aphrodisiac), treatment of psychogenic and functional forms of erectile dysfunction.
Route of administration and doses:
Inside, during food, without chewing, washing down with a glass of water — 5–10 mg 1–3 times a day during 3–10 weeks; if necessary the course is repeated not earlier than in 10 weeks.
Features of use:
With care appoint at the diseases which are followed by risk of development of tachycardia or sharp decrease in the ABP.
Side effects:
Seldom — excitement, a tremor, a headache, dizziness, an abdominal pain, vomiting, diarrhea, orthostatic hypotension, tachycardia, a priapism.
Interaction with other medicines:
There are no data.
Contraindications:
Arterial hypotension, serious illness of a liver and kidneys, concomitant use of adrenomimetik.
Overdose:
Now about cases of overdose of the drug Spiegel Yohimbine it was not reported.
Storage conditions:
In the dry place, at a temperature not above 25 °C.
To store in the place, unavailable to children.
Issue conditions:
Without recipe
Packaging:
In bottles on 20 and 100 pieces; in a box 1 bottle.